English (UK)
中文版Dawei Jiang
China top 3 pharma company in both commercialization and manufacturing sales. Dual listed on HK and Shanghai stock exchange market .
Shanghai Pharma Holding
Sr. BD ManagerQi Jin
Kaitai is a biotech venture fund with about 40 biotech portfolio companies. Kaitai's fund size is about 7 billions dollars. They are positively looking for cutting edge technologies.
Kaitai Capital
董事总裁Kathy Kang
Creacion Ventures is an USD fund of 150million, set up in 2020, focusing on investing cross border biotech companies. We spin off from 6 Dimensions.
Creacion Ventures
associateFrank Lai
biotech company with 18 years technological accumulation. mature technology platform for monoclonal antibody,recombinant protein,vaccine etc. own significant cost competitiveness advantage
sinocelltech sinobiological
BD directorJoe Lai
Fosun Hani Securities Limited is a wholly-owned subsidiary of Fosun International Limited (HKEx: 00656), a leading global investment group (Fosun Group).
Fosun Hani Securities is Fosun Group's integrated financial hub and primary investment arm in Hong Kong. Established in 1995, Fosun Hani Securities is a participant member of The Stock Exchange of Hong Kong Limited (Broker No. 0820 and 0829).
Fosun Hani Securities is Fosun Group's integrated financial hub and primary investment arm in Hong Kong. Established in 1995, Fosun Hani Securities is a participant member of The Stock Exchange of Hong Kong Limited (Broker No. 0820 and 0829).
Responsive Web Design powered by 